Clinical Trials Directory

Trials / Terminated

TerminatedNCT03250195

Non-invasive Detection of Male Infertility With FDG-PET/MRI (Spectroscopy and DWI)

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
12 (actual)
Sponsor
Rigshospitalet, Denmark · Academic / Other
Sex
Male
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

The aim of the study is to examine the value of the new MRI techniques (spectroscopy and DWI), and FDG-PET in prognostication of male infertility.

Detailed description

The diagnostic workup of male infertility includes medical history, physical examination and semen analysis. In severe cases further workup includes testicular ultrasound, analysis of genes and hormones and in a few cases testicular biopsies are necessary. Ultrasound is the first choice of imaging, but new MRI and PET techniques can provide additional information. Research indicates that new MRI techniques can measure the activity of the testicular sperm cell production non-invasively and FDG-PET can measure the testicular metabolism with a radioactively marked glucose analog (FDG). These imaging modalities are combined in a PET/MRI and we wish to perform a PET/MRI in 10 men with normal sperm counts and 10 men with low sperm counts in order to evaluate whether a PET/MRI can distinguish testicles with and without sperm cell production. We hope that this new non-invasive technique can replace the need for invasive biopsies and will be able to target the harvesting of sperm cells in fertility treatment.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTPET/MRIPET/MRI scan

Timeline

Start date
2017-08-07
Primary completion
2021-08-07
Completion
2021-08-07
First posted
2017-08-15
Last updated
2022-11-04

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT03250195. Inclusion in this directory is not an endorsement.